Vertebral Fractures and the Misclassification of Osteoporosis in Men With Prostate Cancer

Journal of Clinical Densitometry

Volumn 14, Issue 3, 2011, Pages 348-353

  Sullivan, Sarah ^a   Wagner, Julie ^a   Resnick, Neil M ^a   Nelson, Joel ^b   Perera, Subashan K ^a   Greenspan, Susan L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Androgen deprivation therapy; Bone mineral density; Osteoporosis; Vertebral fracture assessment; Vertebral fractures

Indexed keywords

ANTIANDROGEN;

ADVANCED CANCER; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE DENSITY; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HIP; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE DIAGNOSIS; RADIUS; SENSITIVITY AND SPECIFICITY; SPINE; SPINE RADIOGRAPHY; TECHNOLOGY; TREATMENT DURATION; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; AGED; ANDROGEN ANTAGONISTS; BONE DENSITY; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PROSTATIC NEOPLASMS; SPINE;

EID: 79960912035     PISSN: 10946950     EISSN: 15590747     Source Type: Journal    
DOI: 10.1016/j.jocd.2011.05.003     Document Type: Article

References (30)

1. Catalona W.J. Management of cancer of the prostate. N Engl J Med 1994, 331:996-1004.
2. Cooperberg M.R., Grossfeld G.D., Lubeck D.P., Carroll P.R. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst 2003, 95:981-989.
3. Zeliadt S.B., Potosky A.L., Etzioni R., et al. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology 2004, 64:1171-1176.
4. Eastham J.A. Bone health in men receiving androgen deprivation therapy for prostate cancer. J Urol 2007, 177:17-24.
5. Israeli R.S., Ryan C.W., Jung L.L. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol 2008, 179:414-423.
6. Krupski T.L., Smith M.R., Lee W.C., et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 2004, 101:541-549.
7. Nevitt M.C., Ettinger B., Black D.M., et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998, 128:793-800.
8. Ensrud K.E., Thompson D.E., Cauley J.A., et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 2000, 48:241-249.
9. Lindsay R., Silverman S.L., Cooper C., et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001, 285:320-323.
10. Fink H.A., Milavetz D.L., Palermo L., et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa?. J Bone Miner Res 2005, 20:1216-1222.
11. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148.
12. Ferrar L., Jiang G., Adams J., Eastell R. Identification of vertebral fractures: an update. Osteoporos Int 2005, 16:717-728.
13. Damiano J., Kolta S., Porcher R., et al. Diagnosis of vertebral fractures by vertebral fracture assessment. J Clin Densitom 2006, 9:66-71.
14. Ferrar L., Jiang G., Clowes J.A., et al. Comparison of densitometric and radiographic vertebral fracture assessment using the algorithm-based qualitative (ABQ) method in postmenopausal women at low and high risk of fracture. J Bone Miner Res 2008, 23:103-111.
15. Kanis J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994, 4:368-381.
16. Greenspan S.L., Nelson J.B., Trump D.L., et al. Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy. J Clin Oncol 2008, 26:4426-4434.
17. Dawson-Hughes B., Jacques P., Shipp C. Dietary calcium intake and bone loss from the spine in healthy postmenopausal women. Am J Clin Nutr 1987, 46:685-687.
18. Townsend M.F., Sanders W.H., Northway R.O., Graham S.D. Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma. Cancer 1997, 79:545-550.
19. Hatano T., Oishi Y., Furuta A., et al. Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer. BJU Int 2000, 86:449-452.
20. Shahinian V.B., Kuo Y.F., Freeman J.L., Goodwin J.S. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005, 352:154-164.
21. Physician's guide to prevention and treatment of osteoporosis 2008, National Osteoporosis Foundation, National Osteoporosis Foundation, Washington, DC.
22. Dietary reference intakes for calcium and vitamin D 2011, Institute of Medicine, The National Academies Press, Washington, DC.
23. Greenspan S.L. Approach to the prostate cancer patient with bone disease. J Clin Endocrinol Metab 2008, 93:2-7.
24. López A.M., Pena M.A., Hernández R., et al. Fracture risk in patients with prostate cancer on androgen deprivation therapy. Osteoporos Int 2005, 16:707-711.
25. Diamond T.H., Bucci J., Kersley J.H., et al. Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy. J Urol 2004, 172:529-532.
26. El Maghraoui A., Mounach A., Gassim S., Ghazi M. Vertebral fracture assessment in healthy men: prevalence and risk factors. Bone 2008, 43:544-548.
27. Freitas S.S., Barrett-Conner E., Ensrud K.E., et al. Rate and circumstances of clinical vertebral fractures in older men. Osteoporos Int 2008, 19:615-623.
28. Fuerst T., Wu C., Genant H.K., et al. Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting. Osteoporos Int 2009, 20:1199-1205.
29. Schousboe J.T., DeBold C.R. Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int 2006, 17:281-289.
30. Greenspan S.L., Coates P., Sereika S.M., et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005, 90:6410-6417.